推荐产品
![4-[4-(二甲基氨基)苯基偶氮]苯甲酸N-琥珀酰亚胺酯 ≥98.0% (HPLC)](/deepweb/assets/sigmaaldrich/product/structures/120/235/500b5276-3ce2-43b7-9588-3883f13d4ff7/640/500b5276-3ce2-43b7-9588-3883f13d4ff7.png)
质量水平
方案
≥98% (HPLC)
表单
solid
颜色
off-white
溶解性
DMSO: ~20 mg/mL
H2O: insoluble
储存温度
2-8°C
SMILES字符串
Brc1ccc(NC(=O)c2cccc(c2)S(=O)(=O)Nc3ccc(Br)cc3)cc1
InChI
1S/C19H14Br2N2O3S/c20-14-4-8-16(9-5-14)22-19(24)13-2-1-3-18(12-13)27(25,26)23-17-10-6-15(21)7-11-17/h1-12,23H,(H,22,24)
InChI key
SJJKUNDBFWUAQB-UHFFFAOYSA-N
生化/生理作用
N-(4-Bromophenyl)-3-[[(4-bromophenyl)amino]sulfonyl]benzamide is the first inhibitor of aggregation of the polyglutamine (polyQ) sequence of the Huntington′s Disease protein (huntingtin); polyQ aggregation is neurotoxic, and inhibitors of aggregation may be therapeutic in HD and other polyQ diseases; C2-8 inhibited aggregation in HD PC12 cells with an IC50 of 50nM; when administered in food, suppressed neurodegeneration in vivo in the Drosophila HD model.
警示用语：
Warning
危险声明
危险分类
Aquatic Chronic 4 - Eye Irrit. 2
储存分类代码
11 - Combustible Solids
WGK
WGK 3
闪点(°F)
Not applicable
闪点(°C)
Not applicable
个人防护装备
dust mask type N95 (US), Eyeshields, Gloves
法规信息
新产品
Xiaoqian Zhang et al.
Proceedings of the National Academy of Sciences of the United States of America, 102(3), 892-897 (2005-01-12)
Polyglutamine (polyQ) disorders, including Huntington's disease (HD), are caused by expansion of polyQ-encoding repeats within otherwise unrelated gene products. In polyQ diseases, the pathology and death of affected neurons are associated with the accumulation of mutant proteins in insoluble aggregates.
我们的科学家团队拥有各种研究领域经验，包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.
联系技术服务部门